Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for Post-renal-transplant Hypertension in Children
NCT00288171Phase 2Withdrawn
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of allopurinol in hypertension (HTN), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Planned start Feb 2006; status: withdrawn.
02
Drugs
allopurinol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00288171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00288171.